In our case, a basophilia, the presence of the Philadelphia chromosome in all metaphases and the strict exclusion of molecular hallmarks of AML lead us to retain the diagnosis of CML-BC rather than <i>BCR-ABL1+</i> AML. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.